TREM-1 splice variant for use in modifying immune responses

Details TREM-1 splice variant for use in modifying immune responses TREM-1 splice variant for use in modifying immune responses

2001-12-07

2010-12-28

Belyavskyi, Michail A (Department: 1644)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Amino acid sequence disclosed in whole or in part; or...

C530S300000, C530S350000

Reexamination Certificate

active

07858094

ABSTRACT:
The present invention relates to a soluble receptor variant of TREM-1. More particularly, present invention relates to methods of modulating an immune response by administering variants of TREM-1.

REFERENCES:
patent: 6087331 (2000-07-01), Newman et al.
patent: 6420526 (2002-07-01), Ruben et al.
patent: 6504010 (2003-01-01), Wang et al.
patent: 1 022 286 (2000-07-01), None
patent: WO-9906557 (1999-02-01), None
patent: WO99/18126 (1999-04-01), None
Feldman et al ., Transplant. Proc. 1998, 30, 4126-4127.
Cochlovius et al ., Modern Drug Discovery, 2003, pp. 33-38.
Van Noort et al. International Review of Cytology, 1998, vol. 178, pp. 127-204.
Mikayama et al. PNAS, 1993. 90: 10056-10060.
Burgess et al J Cell Biol. 111:2129-2138, 1990.
Lazar et al. Mol Cell Biol. 8:1247-1252, 1988.
Ngo et al, in the Protein Folding Problem and Tertiary Structure Prediction, 1994. (ed.), Birkhauser, Boston, MA, pp. 433 and 492-495.
Dietrich, Jes, et al.; Cutting Edge: Signal-Regulatory Protein β1 is a DAP12-Associated Activating Receptor Expressed in Myeloid Cells; The Journal of Immunology, 2000, 164:9-12.
Lanier, Lewis L., et al.; Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells; Nature, vol. 391, pp. 703-707, Feb. 12, 1998.
Bakker, Alexander B., et al.; Myeloid DAP1-associating lectin (MDL)-1 is a cell surface receptor involved in the activation of myeloid cells; Proc. Natl. Acad. Sci. USA, vol. 96, pp. 9792-9796, Aug. 1999 (Immunology).
Lanier, Lewis L.; NK Cell Receptors; Annu. Rev. Immunol. 1998, 16:359-93.
Tapping, Richard I., et al.; Soluble CD14-Mediated Cellular Responses to Lipopolysaccharide; Chem Immunol. Basel, Karger, 2000, vol. 74, pp. 108-121.
Campbell, Kerry S., et al.; DAP12: a key accessory protein for relaying signals by Natural Killer cell receptors; The International Journal of Biochemistry & Cell Biology 31 (1999) 631-636.
Bouchon, Axel, et al.; Cutting Edge: Inflammatory Responses Can Be Triggered by TREM-1, a Novel Receptor Expressed on Neutrophils and Monocytes; The Journal of Immunology, 2000, 164: 4991-4995.
Lanier, Lewis L., et al.; Association of DAP12 with Activating CD94/NKG2C NK Cell Receptors; Immunity, vol. 8, pp. 693-701, Jun. 1998.
European Search Report Application No. 01994219.
Lanier et al, “The IT AM-bearing transmembrane adator DAP 12 in lymphoid and myeloid cell function,” Immunology Today: Viewpoint vol. 21 No. 12, Dec. 2000, pp. 611-614.
Dietrich et al, “Human inhibitory and activating Ig-like receptors which modulate the function of myeloid cells,” Microbes and Infection 2000, pp. 323-329.
Bouchan et al, “TREM-1 amplifies inflammation and is a criucial mediator of septic shock,” Nature vol. 410, Apr. 26, 2001, pp. 1103-1107.
Nochi et al, “Modulation of Hepatic Granulomatous Responses by Transgene Expression of DAP 12 or TREM-1-Ig Molecules,” American Journal of Pathology vol. 162, No. 4, Apr. 2003, pp. 1191-1201.
Wilson et al, “DAP 12 and KAP10 (DAP10)-Novel Transmembrane Adaptor Proteins of the CD3 Family,” Immunologic Research 22/1, 2000, pp. 21-42.
Marie-Claude Gingras, Helene Lapillonne, Judith F. Margolin. TREM-1, MDL-1, and DAP12 expression is associated with a mature stage of myeloid development. Molecular Immunology vol. 38 pp. 817-824, 2001.
Phillipp Haselmeyer, Ludger Grosse-Hovest, Philipp Von Landerberg, Hansjorg Schild, and Markus P. Radsak. TREM-1 ligand expression on platelets enhances neutrophil activation. Blood, vol. 110, pp. 1029-1035, 2007.

Affiliated with

Also associated with

Rating

TREM-1 splice variant for use in modifying immune responses does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with TREM-1 splice variant for use in modifying immune responses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and TREM-1 splice variant for use in modifying immune responses will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4237906